Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis.

Romera I, Pérez V, Ciudad A, Caballero L, Roca M, Polavieja P, Gilaberte I.

BMC Psychiatry. 2013 Feb 11;13:51. doi: 10.1186/1471-244X-13-51.

2.

[Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].

Mouchabac S, Ferreri M, Cabanac F, Bitton M.

Encephale. 2003 Sep-Oct;29(5):438-44. French.

PMID:
14615693
3.

Early symptom change prediction of remission in depression treatment.

Katz MM, Meyers AL, Prakash A, Gaynor PJ, Houston JP.

Psychopharmacol Bull. 2009;42(1):94-107.

PMID:
19204654
4.

The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients.

Farabaugh A, Mischoulon D, Fava M, Wu SL, Mascarini A, Tossani E, Alpert JE.

Int Clin Psychopharmacol. 2005 Mar;20(2):87-91.

PMID:
15729083
5.

Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.

Vaccarino AL, Evans KR, Sills TL, Kalali AH.

Depress Anxiety. 2008;25(12):1006-13. doi: 10.1002/da.20435.

PMID:
18800370
6.
7.

Clinical and functional outcomes in patients with major depressive disorder and painful physical symptoms switched to treatment with duloxetine.

Sheehan DV, Chokka PR, Granger RE, Walton RJ, Raskin J, Sagman D.

Hum Psychopharmacol. 2011 Apr;26(3):242-51. doi: 10.1002/hup.1199.

PMID:
21681815
8.

Anxiety symptoms among remitted depressed outpatients: prevalence and association with quality of life and psychosocial functioning.

D'Avanzato C, Martinez J, Attiullah N, Friedman M, Toba C, Boerescu DA, Zimmerman M.

J Affect Disord. 2013 Oct;151(1):401-4. doi: 10.1016/j.jad.2013.06.040. Epub 2013 Jul 23.

PMID:
23890581
9.

Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.

Sheehan DV, Harnett-Sheehan K, Spann ME, Thompson HF, Prakash A.

Int Clin Psychopharmacol. 2011 Mar;26(2):75-83. doi: 10.1097/YIC.0b013e328341bb5f.

PMID:
21102344
10.

Residual anxiety symptoms in depressed primary care patients.

McIntyre RS, Konarski JZ, Soczynska JK, Kennedy SH.

J Psychiatr Pract. 2007 Mar;13(2):125-8.

PMID:
17414691
11.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
12.

Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.

Shelton RC, Prakash A, Mallinckrodt CH, Wohlreich MM, Raskin J, Robinson MJ, Detke MJ.

Int J Clin Pract. 2007 Aug;61(8):1337-48. Review.

PMID:
17627710
13.

The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.

Arnold LM, Meyers AL, Sunderajan P, Montano CB, Kass E, Trivedi M, Wohlreich MM.

Ann Clin Psychiatry. 2008 Oct-Dec;20(4):187-93. doi: 10.1080/10401230802435609.

PMID:
19034749
15.

Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.

Nierenberg AA, Husain MM, Trivedi MH, Fava M, Warden D, Wisniewski SR, Miyahara S, Rush AJ.

Psychol Med. 2010 Jan;40(1):41-50. doi: 10.1017/S0033291709006011. Epub 2009 May 22.

PMID:
19460188
16.

Individual residual symptoms and functional impairment in patients with depression.

Romera I, Pérez V, Quail D, Berggren L, Lenox-Smith A, Gilaberte I.

Psychiatry Res. 2014 Dec 15;220(1-2):258-62. doi: 10.1016/j.psychres.2014.07.042. Epub 2014 Aug 1.

PMID:
25149132
18.

Predictors of remission with placebo using an integrated study database from patients with major depressive disorder.

Nelson JC, Zhang Q, Deberdt W, Marangell LB, Karamustafalioglu O, Lipkovich IA.

Curr Med Res Opin. 2012 Mar;28(3):325-34. doi: 10.1185/03007995.2011.654010. Epub 2012 Jan 31.

PMID:
22292447
19.

[Association between health related quality of life and severity of depression in patients with major depressive disorder].

Cao Y, Li W, Shen J, Zhang Y.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Feb;36(2):143-8. doi: 10.3969/j.issn.1672-7347.2011.02.009. Chinese.

20.

Clinical differences between early and late remission in depressive patients.

Roca M, García-Toro M, García-Campayo J, Vives M, Armengol S, García-García M, Asensio D, Gili M.

J Affect Disord. 2011 Nov;134(1-3):235-41. doi: 10.1016/j.jad.2011.05.051. Epub 2011 Jun 14.

PMID:
21676465

Supplemental Content

Support Center